You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA2

Showing 26 - 50 of 861
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

Completed
Has Results
  • Breast Neoplasms
  • KU-0059436 (AZD2281) (PARP inhibitor)
  • West Hollywood, California
  • +16 more
Jan 24, 2023

TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +2 more
  • (no location specified)
Jan 12, 2022

Breast & Ovarian Cancer Risk Detection

Recruiting
  • Adnexal Mass
  • +3 more
  • OVA360
  • Austin, Texas
    Silvana Franco
Jul 20, 2022

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Impact of Positive BRCA1/2 Mutation Status on Lives of Young

Completed
  • BRCA1 Gene
  • BRCA2 Gene
    • Bethesda, Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike
    Nov 26, 2021

    Registry of Subjects at Risk of Pancreatic Cancer

    Recruiting
    • Familial Pancreatic Cancer
    • +6 more
    • MRCP
    • Endoultrasonography
    • Rozzano, Milan, Italy
    • +3 more
    Jan 12, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

    Recruiting
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
    • Informational Intervention
    • Survey Administration
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 2, 2022

    Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors

    Recruiting
    • Breast Cancer
    • +3 more
      • Stanford, California
        Stanford University School of Medicine
      Sep 2, 2021

      Prospective Research of Outcomes After Salpingo-oophorectomy

      Active, not recruiting
      • BRCA1 Gene Mutation
      • BRCA2 Gene Mutation
        • San Francisco, California
          University of California, San Francisco
        Mar 21, 2022

        Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +7 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 21, 2022

        Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

        Not yet recruiting
        • Pancreatic Acinar Cell Carcinoma
        • +6 more
        • Nab paclitaxel
        • +5 more
        • (no location specified)
        Oct 30, 2023

        Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

        Active, not recruiting
        • Advanced Lymphoma
        • +5 more
        • Philadelphia, Pennsylvania
          ECOG-ACRIN Cancer Research Group
        Jun 28, 2022

        Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

        Active, not recruiting
        • Pancreatic Cancer
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Nov 10, 2021

        HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

        Completed
        • Epithelial Ovarian Cancer
        • +6 more
        • Evaluation of homologous recombination deficiency score
        • Beijing, Beijing, China
          Lei Li
        Mar 26, 2022

        BRCA and NACT in TNBC Patients

        Completed
        • Triple-Negative Breast Cancer
        • BRCA1/2 genetic testing
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Feb 20, 2023

        Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

        Enrolling by invitation
        • Breast Cancer
        • +7 more
        • Dnipro, Ukraine
        • +1 more
        Jun 17, 2023

        Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

        Active, not recruiting
        • Deleterious BRCA1 Gene Mutation
        • +5 more
        • Behavioral, Psychological or Informational Intervention
        • Questionnaire Administration
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 22, 2022

        An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

        Recruiting
        • Prostate Cancer
        • +2 more
        • MRI pelvis or CT imaging
        • +2 more
        • London, Sutton, Surrey, United Kingdom
          Cancer Genetics Unit, Royal Marsden Hospital
        Mar 30, 2022

        BRCA Founder OutReach (BFOR) Study

        Active, not recruiting
        • BRCA1 Mutation
        • BRCA2 Mutation
        • BFOR Digital Health solution/Web Portal
        • Los Angeles, California
        • +4 more
        May 11, 2022

        Nipple-sparing Mastectomy, Prophylactic Mastectomy, Breast Cancer Trial in Taoyuan (da Vinci SP? Single-port System)

        Recruiting
        • Nipple-sparing Mastectomy
        • +4 more
        • da Vinci SPⓇ Single-port System
        • Taoyuan, Taiwan
          Chang Gung Memeorial Hospital, Linkou Medical Center
        Jul 29, 2022

        Dietary Modification, BRCA1 Mutation, BRCA2 Mutation Trial in Milano (Dietary intervention)

        Completed
        • Dietary Modification
        • +3 more
        • Dietary intervention
        • Milano, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori
        Sep 27, 2021

        ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

        Recruiting
        • ATM Gene Mutation
        • +16 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 27, 2022

        Gynecologic Cancer, Breast Cancer, BRCA1 Mutation Trial in New York (Web-based family health history tool)

        Active, not recruiting
        • Gynecologic Cancer
        • +3 more
        • Web-based family health history tool
        • New York, New York
          Weill Cornell Medicine
        Feb 23, 2022

        Germline Mutations Associated With Hereditary Pancreatic Cancer

        Recruiting
        • Pancreatic Cancer
        • Pancreatic Adenocarcinoma
        • Invitae Multi-Cancer Panel ®
        • Mexico City, Mexico
          Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
        Mar 22, 2022

        Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

        Recruiting
        • Breast Cancer
        • Genetic Predisposition
        • Genetic predisposition to breast cancer
        • Rome, Italy
        • +1 more
        May 4, 2023